Novel insights into autophagy and prostate cancer: a comprehensive review

D Loizzo, SD Pandolfo, D Rogers, C Cerrato… - International Journal of …, 2022 - mdpi.com
Autophagy is a complex process involved in several cell activities, including tissue growth,
differentiation, metabolic modulation, and cancer development. In prostate cancer …

Curcumin in the treatment of urological cancers: Therapeutic targets, challenges and prospects

M Hashemi, S Mirzaei, M Barati, ES Hejazi… - Life sciences, 2022 - Elsevier
Urological cancers include bladder, prostate and renal cancers that can cause death in
males and females. Patients with urological cancers are mainly diagnosed at an advanced …

Metformin-based carbon dots based on biguanide functional groups for simultaneous chelation of copper ions and inhibitable colorectal cancer therapy

L Yu, Y Wang, K Li, X Li, M He, C Chen, F Li, B Liang… - Carbon, 2023 - Elsevier
Colorectal cancer (CRC) is the most common malignancy-related cause of death worldwide.
The prognosis of CRC patients is strongly correlated with elevated plasma copper. The …

The endoplasmic reticulum stress response in prostate cancer

CM de la Calle, K Shee, H Yang, PE Lonergan… - Nature Reviews …, 2022 - nature.com
In order to proliferate in unfavourable conditions, cancer cells can take advantage of the
naturally occurring endoplasmic reticulum-associated unfolded protein response (UPR) via …

Molecular landscape of c-Myc signaling in prostate cancer: A roadmap to clinical translation

MA Faskhoudi, P Molaei, M Sadrkhanloo… - … -Research and Practice, 2022 - Elsevier
The c-Myc signaling is a new emerging target in cancer therapy. Activation of c-Myc
signaling leads to cancer growth and invasion in vitro and in vivo. The stability of c-Myc can …

Metformin use and mortality in Asian, diabetic patients with prostate cancer on androgen deprivation therapy: A population‐based study

YHA Lee, JMH Hui, JSK Chan, K Liu, EC Dee… - The …, 2023 - Wiley Online Library
Background This study aims to examine the associations between metformin use concurrent
with androgen deprivation therapy (ADT) and mortality risks in Asian, diabetic patients with …

Autophagy, a critical element in the aging male reproductive disorders and prostate cancer: a therapeutic point of view

P Raee, SC Tan, S Najafi, F Zandsalimi, TY Low… - Reproductive Biology …, 2023 - Springer
Autophagy is a highly conserved, lysosome-dependent biological mechanism involved in
the degradation and recycling of cellular components. There is growing evidence that …

Metformin and cancer hallmarks: molecular mechanisms in thyroid, prostate and head and neck cancer models

MG Morale, RE Tamura, IGS Rubio - Biomolecules, 2022 - mdpi.com
Metformin is the most used drug for type 2 diabetes (T2DM). Its antitumor activity has been
described by clinical studies showing reduced risk of cancer development in T2DM patients …

Phenformin activates ER stress to promote autophagic cell death via NIBAN1 and DDIT4 in oral squamous cell carcinoma independent of AMPK

D Zhuang, S Wang, H Deng, Y Shi, C Liu… - International Journal of …, 2024 - nature.com
The efficient clinical treatment of oral squamous cell carcinoma (OSCC) is still a challenge
that demands the development of effective new drugs. Phenformin has been shown to …

The role of autophagy in prostate cancer and prostatic diseases: a new therapeutic strategy

G Lemos, CMAS Fernandes, FH Silva… - Prostate Cancer and …, 2024 - nature.com
Background Autophagy is a well-conserved catabolic process that plays a key role in cell
homeostasis. In the prostate, defective autophagy has been implicated in the genesis and …